All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-T-2-LX505 | Anti-HIV (PGT135) (CD4-scFv-h(CD28-CD3ζ)) CAR, pCDCAR1 | Human | PGT135 | Human | CD4-scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-T-2-LX506 | Anti-HIV (PGT137) (CD4-scFv-h(CD28-CD3ζ)) CAR, pCDCAR1 | Human | PGT137 | Human | CD4-scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-T-2-LX746 | Anti-HIV (PGT135) (CD4-scFv-h(4-1BB-CD3ζ)) CAR, pCDCAR1 | Human | PGT135 | Human | CD4-scFv-4-1BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-T-2-LX747 | Anti-HIV (PGT137) (CD4-scFv-h(4-1BB-CD3ζ)) CAR, pCDCAR1 | Human | PGT137 | Human | CD4-scFv-4-1BB-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION